Hyderabad, March 14 -- Cambridge Isotope Laboratories, Inc. (CIL), a global leader in stable isotope-labelled compounds, in collaboration with Hyderabad-based speciality chemicals manufacturer Chemtatva Chiral Solutions Pvt Ltd., on Saturday announced a strategic joint venture to establish advanced manufacturing capabilities in Telangana.
The joint venture plans to invest up to Rs 300 crore over the next three years in Genome Valley Phase 4 in Hyderabad, creating over 250 direct, high-skilled jobs and strengthening India's position in manufacturing isotopically labelled molecules used in pharmaceutical research, diagnostics, advanced electronics, OLED materials, and semiconductor applications.
The announcement follows a meeting between th...